Tuesday 5 April 2022

Tuesday 5 April 2022 

07:00 [PDT] 10:00 [EDT] 15:00 [BST]

Hi there,

Join our webinar 'From PCR to biomarkers: a case study evaluation of bioanalytical challenges in cell and gene therapy products'. Polymerase chain reaction (PCR) and next generation sequencing (NGS) techniques are fairly well-established, yet we run into bioanalytical issues in biomarker, quantitative PCR, digital drop PCR and traditional pharmacokinetic assays as they pertain to cell and gene therapy.

By means of case studies, we will identify and discuss some common bioanalytical issues and possible solutions to be able to better adopt these technologies to develop cell and gene therapy products.

All event attendees will have the opportunity to download a certificate of attendance as well.

What will you learn?

• What platforms are being used for cell and gene therapy programs and why
• How are acceptance criteria applied when specifications from health authorities are not available
• For biomarkers – when are CLIA assays appropriate and when would FDA regulated fit-for-purpose assays provide a better approach

For more webinars, please visit our webinar page.
Interested in running your own webinar? Click here to find out more.